MAPK3 and pulmonary arterial hypertension: Next, we tested the effects of studied antibodies on the phosphorylation of Akt, ERK1/2 and p38 MAPK, non-canonical targets of TGF-β signaling—known pro-proliferative players in PAH pathogenesis [6,40].